Dáil Éireann Debate, Tuesday - 18 October 2016
438. Deputy Eamon Ryan asked the Minister for Health if his Department has given consideration to the provision of pre-exposure prophylaxis, PrEP, medication (details supplied) to groups who are at high risk of contracting HIV; and if he will make a statement on the matter. [30442/16]
View answerThe National Sexual Health Strategy 2015-2020 was launched in October 2015. The strategy was developed in response to a recommendation of the National AIDS Strategy Committee on the need to establish clear leadership within the health sector around the area of sexual health. The Strategy contains 71 recommendations that address all aspects of sexual health and a Sexual Health Action Plan for 2015-2016 that contains 18 priority actions for immediate attention.
One of the priority actions identified in the Action Plan for 2016 is to 'Prioritise, develop and implement guidance to support clinical decision making for STI testing, screening and treatment and on the appropriate use of antiretroviral therapy in HIV prevention’. An Implementation Group has now been established within the HSE as an outcome of this action. This group will make recommendations on the appropriate use of HIV pre-exposure prophylaxis (PrEP) in the overall context of the national approach to HIV prevention.
Truvada has been approved by the Health Products Regulatory Authority for use, in combination with safer sex practices, for PrEP to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.
